March 9, 2017 / 10:21 PM / 8 months ago

BRIEF-Cara Therapeutics Q4 loss per share $0.81

March 9 (Reuters) - Cara Therapeutics Inc:

* Cara Therapeutics reports fourth quarter and full year 2016 financial results

* Q4 loss per share $0.81

* Q4 earnings per share view $-0.48 -- Thomson Reuters I/B/E/S

* Cara Therapeutics - expects that cash equivalents as of Dec 31, 2016 to be sufficient to fund operating, capital expenditures through end of Q1 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below